Article Detail

Home > Article Detail
  • P-ISSN 1010-0695
  • E-ISSN 2288-3339

Successful Outcome of an Elderly Patient with Small Cell Lung Cancer with only Alternative Treatments: A Case Report

Journal of Korean Medicine / Journal of Korean Medicine, (P)1010-0695; (E)2288-3339
2018, v.39 no.4, pp.171-176
https://doi.org/10.13048/jkm.18043

Jeonghyun Joo

  • Downloaded
  • Viewed

Abstract

Background: Small cell lung cancer (SCLC) tends to grow more rapidly and spread much faster than non-small cell lung cancer (NSCLC). A concurrent combination of chemotherapy and thoracic radiotherapy is suggested as the standard conventional treatment, but it is more challenging for elderly patients having pulmonary and cardiovascular comorbidities. Case presentation: Here we present a case of an 80-year-old male, curre1nt smoker diagnosed with SCLC in limited stage T3N0M0 (36mm right upper lobe, satellite nodule) in Dec, 2015. The standard concurrent chemoradiotherapy was not available for his comorbidities, which included chronic obstructive pulmonary disease (COPD) and angina pectoris. Furthermore, he and his family refused the recommended chemotherapy or radiotherapy exclusively. Alternatively, he received various non-conventional treatments including local radiofrequency hyperthermia, mistletoe, and Traditional Korean medicine including acupuncture, moxibustion and herbs since Jan. 2016. Despite the progression in primary tumor size, there have been no other distant relapse so far, and the patient has been in stable condition ever since. Conclusion: We suggest that a combination of various alternative treatments could be a candidate for elderly patients intolerable to conventional cytotoxic treatments.

keywords
Small cell lung cancer, Elderly patients, Alternative therapy


Reference

1

1. Arcaro A. Targeted therapies for small cell lung cancer: Where do we stand? Crit Rev Oncol Hemat. 2015;95(2):154-64.

2

2. van Meerbeeck JP, Fennell DA, De Ruysscher DK. Small-cell lung cancer. Lancet. 2011;378(9804):1741-55.

3

3. Stupp R, Monnerat C, Turrisi AT, 3rd, Perry MC, Leyvraz S, Small cell lung cancer: state of the art and future perspectives. Lung Cancer. 2004;45(1):105-17.

4

4. De Ruysscher D, Botterweck A, Dirx M, Pijls-Johannesma M, Wanders R, Hochstenbag M, et al. Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study. Annals of Oncology, 2009;20(1):98-102.

5

5. Owonikoko TK, Ragin CC, Belani CP, Oton AB, Gooding WE, Taioli E, et al. Lung cancer in elderly patients: An analysis of the surveillance, epidemiology, and end results database. Journal of Clinical Oncology. 2007;25(35):5570-7.

6

6. Kato Y, Ferguson TB, Bennett DE, Burford TH. Oat cell carcinoma of the lung. A review of 138cases. Cancer. 1969;23(3):517-24.

7

7. Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nature medicine. 2013;19(11):1423-37.

8

8. Chabner BA, Roberts TG. Timeline - Chemotherapy and the war on cancer. Nature Reviews Cancer. 2005;5(1):65-72.

9

9. Kang CH, Kang H, Shin HK, Shim BS, Kim SH, Choi SH, et al. Experimental Studies on the Anti-angiogenesis and Anti-metastasis Effects of Ekong-san. Journal of Korean traditional oncology. 2006;11(1):41-54.

10

10. Lee SG, Ha JH. Antitumor and immunomodulatory effects of Ikongsan on murine melanoma-induced lung metastasis. Koren Journal of Oriental Medical Pathology. 1997;11(1):21-30.

11

11. Kuroiwa A, Liou S, Yan H, Eshita A, Naitoh S, Nagayama A. Effect of a traditional Japanese herbal medicine, hochu-ekki-to (Bu-Zhong-Yi-Qi Tang), on immunity in elderly persons. Int Immunopharmacol. 2004;4(2):317-24.

12

12. Nabeshima S, Murata M, Hamada M, Chong Y, Yamaji K, Hayashi J. Maturation of monocytederived dendritic cells by Hochu-ekki-to, a traditional Japanese herbal medicine. Int Immunopharmacol. 2004;4(1):37-45.

13

13. Li T, Tamada K, Abe K, Tada H, Onoe Y, Tatsugami K, et al. The restoration of the antitumor T cell response from stress-induced suppression using a traditional Chinese herbal medicine Hochu-ekki-to (TJ-41:Bu-Zhong-Yi-Qi-Tang). Immunopharmacology. 1999;43(1):11-21.

14

14. Choi W, Jung H, Kim K, Lee S, Yoon S, Park J, et al. Rhus verniciflua Stokes against Advanced Cancer: A Perspective from the Korean Integrative Cancer Center. Journal of biomedicine &biotechnology. 2012;2012:874276.

15

15. Szasz A. Current status of oncothermia therapy for lung cancer. The Korean journal of thoracic and cardiovascular surgery. 2014;47(2):77-93.

16

16. Hegyi G, Szigeti GP, Szasz A. Hyperthermia versus Oncothermia: Cellular Effects in Complementary Cancer Therapy. Evidence-based complementary and alternative medicine : eCAM. 2013;2013:672873.

17

17. Melzer J, Iten F, Hostanska K, Saller R. Efficacy and Safety of Mistletoe Preparations (Viscum album) for Patients with Cancer Diseases A Systematic Review. Forschende Komplementarmedizin. 2009;16(4):217-26.

18

18. Elluru SR, Van Huyen JPD, Delignat S, Prost F, Heudes D, Kazatchkine MD, et al. Antiangiogenic Properties of Viscum Album Extracts Are Associated with Endothelial Cytotoxicity. Anticancer research. 2009;29(8):2945-50.

  • Downloaded
  • Viewed
  • 0KCI Citations
  • 0WOS Citations

Other articles from this issue

Recommanded Articles

상단으로 이동

Journal of Korean Medicine